Evaluation of deoxycoformycin in patients with advanced renal cell carcinoma
- 1 March 1992
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 10 (1) , 49-50
- https://doi.org/10.1007/bf01275482
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- 2′-Deoxycoformycin (Pentostatin) for Lymphoid MalignanciesAnnals of Internal Medicine, 1988
- Deoxycoformycin treatment for childhood T‐cell acute lymphoblastic leukemia early in second remission: A pediatric oncology group studyMedical and Pediatric Oncology, 1988
- Remissions in Hairy-Cell Leukemia with Pentostatin (2′-Deoxycoformycin)New England Journal of Medicine, 1987
- ALTERATIONS IN ERYTHROCYTE ADENINE-NUCLEOTIDE POOLS RESULTING FROM 2'-DEOXYCOFORMYCIN THERAPY1983
- THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIAThe Lancet, 1981
- The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyBlood, 1981
- THE BIOCHEMICAL AND CLINICAL CONSEQUENCES OF 2'-DEOXYCOFORMYCIN IN REFRACTORY LYMPHOPROLIFERATIVE MALIGNANCY1981